| 24小時(shí)熱門版塊排行榜 |
| 5 | 1/1 | 返回列表 |
| 查看: 3188 | 回復(fù): 14 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | |||
[交流]
JPBA 投稿被拒,貼出拒稿信,求指點(diǎn) 已有5人參與
|
|||
|
Dear Dr. Zhu, I regret to inform you that, after consideration of our reviewers' comments on your paper (with which I fully agree), I'm unable to accept it for publication. For your guidance, I append the reviewers' comments below. Please note that a great many more papers are submitted to JPBA than we can possibly publish. The acceptance rate for papers is about 25% and our decision is not a reflection of the quality of your research but rather of our stringent requirements. The Editors hope that you do understand the above decision, and we appreciate your continued interest in the Journal of Pharmaceutical and Biomedical Analysis. Thank you for giving us the opportunity to consider your work. We wish you every success when you submit the paper elsewhere. Yours sincerely, Sándor Görög Editor Journal of Pharmaceutical and Biomedical Analysis Reviewers' comments: Reviewer #1: This paper is about Identification of major compounds in rat bile, plasma and urine after oral administration of Radix Scutellariae extract by ultra-fast liquid chromatography coupled to ion trap time-of-flight mass spectrometry. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in JPBA. 1. It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure. 2. The innovation of this manuscript is weak and the content of experiments is not plentiful. 3. The Fig.4 and Fig.4 are not clearly expressed, and the Fig.5 should be deleted. It will be nice if you can add the schematic diagram of the cracking. Based on what was described above this manuscript is not suitable for publication in the journal of JPBA. We suggest that the authors try submitting their findings to other journals. Reviewer #2: I do not recommend the publication of this manuscript due mainly to the lack of scientific novelty and for neglecting the comparison of the authors' method and results with those in the literature. The Guide for Authors of JPBA contains the following restriction: "In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods." The authors have missed to make reference to closely related papers such as Ling Tong, Meixu Wan, Lihua Zhang, Yonghong Zhu, He Sun, Kaishun Bi, Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2012) (from the same university!!!) and Chung, H.J., Lim, S., Kim, I.S., Bu, Y., Kim, H., Kim, D.-H., Yoo, H.H., Simultaneous determination of baicalein, baicalin, wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract of scutellariae radix, Bulletin of the Korean Chemical Society, 33 (2012) 177-182. Reference has been made to [23] but real comparison was not made. |
新蟲(chóng) (職業(yè)作家)
術(shù)中小生
新蟲(chóng) (職業(yè)作家)
術(shù)中小生
|
我仔細(xì)看了審稿意見(jiàn)。 首先不要再投JPBA了,通過(guò)幾點(diǎn)老鼠,利用LC/MS進(jìn)行簡(jiǎn)單地鑒定入血成分,自去年JPBA就不收了。隨著IF的增長(zhǎng),其在代謝方面要求顯著提高。 審稿人認(rèn)為你的方法沒(méi)有什么特色,換句話說(shuō)你的發(fā)現(xiàn)沒(méi)有什么閃光點(diǎn)。另外一定得和已報(bào)道文獻(xiàn)進(jìn)行比對(duì),說(shuō)明你方法的先進(jìn)性。任何文章只報(bào)道自己東西,沒(méi)有和先前文獻(xiàn)對(duì)比的話,肯定是一短板。尤其遇到做過(guò)相關(guān)研究的審稿人,他認(rèn)變你沒(méi)有好好看文獻(xiàn)。 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料考研調(diào)劑 +3 | Gs大王 2026-04-02 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 279求調(diào)劑 +3 | 學(xué)而思兮知 2026-04-01 | 3/150 |
|
|
[考研] 266分,一志愿電氣工程,本科材料,求材料專業(yè)調(diào)劑 +8 | 哇呼哼呼哼 2026-04-01 | 8/400 |
|
|
[考研] 085600,320分求調(diào)劑 +5 | 大饞小子 2026-04-01 | 6/300 |
|
|
[考研] 【求調(diào)劑】085601材料工程專碩 | 總分272 | +10 | 腳滑的守法公民 2026-03-27 | 10/500 |
|
|
[碩博家園] 博一被送出聯(lián)培感覺(jué)不適應(yīng)怎么辦 +3 | 全村的狗 2026-03-31 | 3/150 |
|
|
[考研] 358求調(diào)劑 +3 | 王向陽(yáng)花 2026-03-31 | 3/150 |
|
|
[考研] 生物學(xué)308分求調(diào)劑(一志愿華東師大) +3 | 相信必會(huì)光芒萬(wàn)?/a> 2026-03-31 | 3/150 |
|
|
[考研] 求調(diào)劑:一志愿:南京大學(xué) 專業(yè):0705 總分320 ,本科985,四六級(jí)已過(guò) +3 | lfy760306 2026-03-31 | 3/150 |
|
|
[考研] 086000調(diào)劑 +5 | 7901117076 2026-03-26 | 5/250 |
|
|
[考研] 生醫(yī)工0831調(diào)劑求推薦 +4 | 小熊睿睿_s 2026-03-27 | 6/300 |
|
|
[考研] 322求調(diào)劑:一志愿湖南大學(xué) 材料與化工(085600),已過(guò)六級(jí)。 +10 | XX小鄧 2026-03-29 | 10/500 |
|
|
[考研] 289求調(diào)劑 +3 | Acesczlo 2026-03-29 | 4/200 |
|
|
[考研] 南京大學(xué)化學(xué)調(diào)劑 +11 | 景隨風(fēng) 2026-03-29 | 16/800 |
|
|
[考研] 282求調(diào)劑 +3 | 呼吸都是減肥 2026-03-31 | 3/150 |
|
|
[考研] 323分 食品與營(yíng)養(yǎng)調(diào)劑 +3 | 嘿ooo 2026-03-31 | 3/150 |
|
|
[考研] 327求調(diào)劑 +5 | 小卡不卡. 2026-03-29 | 5/250 |
|
|
[考研] 305求調(diào)劑 +8 | RuiFairyrui 2026-03-28 | 8/400 |
|
|
[考研] 本科新能源科學(xué)與工程,一志愿華理能動(dòng)285求調(diào)劑 +7 | AZMK 2026-03-28 | 11/550 |
|
|
[考研] 272求調(diào)劑 +7 | 腳滑的守法公民 2026-03-27 | 7/350 |
|